Compare Figs Inc (FIGS) vs Synopsys, Inc. (SNPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Figs Inc vs Synopsys, Inc. — how do they compare? Figs Inc trades at $10.14 (market cap $1.66B), while Synopsys, Inc. trades at $420.84 (market cap $81.43B). The key difference: Synopsys, Inc. is far larger — about 49.1× Figs Inc's market cap, and Figs Inc is trading nearer its 52-week high, Synopsys, Inc. nearer its low. Which is the better fit depends on your goals.
| FIGS | SNPS | |
|---|---|---|
Market Cap | $1.66B | $81.43B |
Sector | Consumer Cyclical | Technology |
52-Week High | $17.12 | $645.59 |
52-Week Low | $5.81 | $380.47 |
Enterprise Value | $1.44B | $89.79B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FIGS trades at $9.72, down 2.8% today, amid bearish technical signals despite recent earnings beats. Revenue grew to $631M in 2025 with a 66.6% gross margin, but net cash flow remains negative. Analyst consensus is bullish with a $19.50 price target, though technical indicators show selling pressure with RSI at neutral levels and ADX signaling a strong downtrend.
The stock presents a growth opportunity with strong fundamentals and analyst support, but faces near-term technical headwinds and margin pressures from tariffs and freight costs. Investors should weigh the 100% upside to consensus target against execution risks and persistent negative cash flow trends.
Synopsys (SNPS) trades at $425.81, down 1.85% amid bearish technical signals, though it maintains strong analyst support with 82.8% buy ratings and a $559.50 consensus target. The company shows consistent earnings beats and robust revenue growth to $7.05B in 2025, though profitability metrics like net margin (8.91%) and ROE (3.83%) are tempered by high valuations (P/E 97.32). Recent news highlights its strategic pivot to AI-driven design tools and the integration of Ansys, positioning it as a key enabler in the semiconductor ecosystem.
The outlook remains positive given SNPS's strategic positioning in AI and semiconductor design, with significant upside to analyst targets. Risks include execution challenges from the Ansys integration, competitive pressures, and sensitivity to semiconductor cycles. Investors should weigh high valuation multiples against growth potential in the expanding AI market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Figs Inc
FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →About Synopsys, Inc.
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →
